$BME

BlackRock Health Sciences Trust (NYSE: BME) director reports no holdings in initial insider filing

BlackRock Health Sciences Trust (BME) filed an initial insider statement for director Francis C. Mahoney, reporting no transactions or holdings. The Form 3 indicates Mahoney's director role but lists no derivative positions or trading plans.

Original reporting
Published Sep 17, 2026, 9:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 1:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BME
Neutral
high confidence
Mentioned
$BME
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BMENeutralLow
01

Why it matters

The filing confirms no current stake, offering no actionable insight.

02

Market read

Routine regulatory filing with no material change.

03

What to watch

Potential future transactions by the director are not disclosed.

Relevance 4/10Novelty 2/10Timing: filing date

Background

Form 3 is an initial insider ownership statement required when a person becomes a director.

Company-level read

Ticker impact

$BMENeutralHigh confidence
Context

Initial Form 3 filing shows director Mahoney has no holdings or transactions.

Expected impact

No immediate price effect expected.

Evidence & confidence

The filing reports zero holdings and zero transactions, providing no new material information for traders.

Market effects

None

None

None

Counterpoint

Even a zero‑holding filing could hint at upcoming insider activity, but no evidence yet.

Key entities

  • Francis C. Mahoney

    Director of BlackRock Health Sciences Trust with no reported holdings.

Related articles

$BMEMed

B&M falls after reporting soft UK trading - UDPATE

B&M European Value Retail SA (LSE:BME) shares fell 4.1% to 195.7p after a mixed Q1 trading update. Revenue rose 2% to £1.43bn in the 13 weeks to 27 June. B&M UK revenue edged up to £1.14bn, but like-for-like sales fell 2.3%. France grew, and Heron Foods improved. Peel Hunt said the UK decline matched forecasts.

$LMTHighAI 9/10

World News: Washington clears way for fighter jets sale to Saudi

The US approved a potential $24.3B sale of 48 Lockheed Martin F-35 fighter jets to Saudi Arabia, including engines and support equipment. The sale, a policy shift, may alter Middle East military balance and test US commitment to Israel's military edge. Saudi Arabia has long sought the advanced jets to modernize its air force and counter regional threats, particularly from Iran.

$LMTHighAI 9/10

35 sale for Saudi Arabia

The US State Department approved a potential $24.3B sale of 48 F-35A fighters and 49 engines to Saudi Arabia, including support equipment and training. Lockheed Martin, the manufacturer, and RTX subsidiary Pratt & Whitney are involved. The deal requires congressional review and could face opposition due to security concerns. If finalized, it would make Saudi Arabia the 20th operator of the F-35.

$LHXMed

Inside L3Harris Technologies (LHX)’s C-HOBS Contract: What the $60M Air Force Award Means for Investors

L3Harris Technologies (LHX) secured a $60M contract from the U.S. Air Force for C-HOBS sensors. The order supports production at its Cincinnati facility and adds to the company's record backlog of $42B. LHX's Missile Solutions division, which includes this contract, saw Q2 revenue increase 14% YoY to $1.05B. The stock has fallen 19% since July, with hedge fund ownership dropping 5% in Q2.

$CACIMedAI 8/10

UAS for USSOUTHCOM

The Department of War allocated over $25 million to enhance counter-unmanned aircraft systems (C-UAS) for U.S. Southern Command. The funds will support interceptors, electronic warfare, and tracking capabilities. Army Brig. Gen. Matt Ross noted the task force is accelerating C-UAS deployment. Previous awards include $13 million for U.S. Central Command and $500 million contracts for Perennial Autonomy and CACI.